However, some studies have proved that the mice with mutations in TGFBR2 have enhanced potential in tumor metastasis (43), and TGFBR2 receptor inhibitors enable reduced lung metastasis in squamous cell carcinoma (44). The gene discussed is TGFBR2; the disease is squamous cell carcinoma.